| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chairman And CEO | Chairman, President And CEO +3 more
3 companies
Sapirstein James is a Chief Executive Officer at Hepion Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 7 sells.
Estimated insider holdings value: $159K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | GRDX Gridai Technologies Corp. | Chairman And CEO | Sell | 1,289 | $1.07 | $1,379.23 | -3.5% | -64.9% | -58.7% | |
| Apr 1, 2024 | GRDX Gridai Technologies Corp. | Chairman And CEO | Sell | 174 | $4.23 | $735.92 | -0.5% | -73.6% | -90.3% | |
| Mar 15, 2024 | GRDX Gridai Technologies Corp. | Chairman And CEO | Sell | 1,887 | $4.96 | $9,359.52 | -4.8% | -53.6% | -89.8% | |
| Jan 12, 2024 | GRDX Gridai Technologies Corp. | Chairman, President And CEO | Sell | 166 | $4.20 | $697.20 | -0.4% | -15.6% | -85.4% | |
| Oct 4, 2023 | GRDX Gridai Technologies Corp. | President And CEO | Sell | 2,764 | $0.29 | $801.56 | -7.6% | -35.7% | -94.1% | |
| Jul 3, 2023 | GRDX Gridai Technologies Corp. | President And CEO | Sell | 3,349 | $1.54 | $5,157.46 | -8.5% | -80.5% | -96.8% | |
| Apr 3, 2023 | GRDX Gridai Technologies Corp. | President And CEO | Sell | 3,347 | $2.50 | $8,367.50 | -7.8% | -37.2% | -91.6% | |
| Feb 18, 2016 | HEPA Hepion Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 10,000 | $1.00 | $10,000.00 | +333.3% | - | - | |
| Nov 30, 2015 | HEPA Hepion Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 500 | $2.15 | $1,075.00 | +20.0% | - | - | |
| Nov 23, 2015 | HEPA Hepion Pharmaceuticals, Inc. | Chief Executive Officer | Buy | 2,500 | $1.64 | $4,100.00 | New | - | - |